We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
BioMarin Pharmaceuticals
BMRN
$13.4B
| $663K | ﹤0.01% |
8,049
+1,939
| +32% | +$154K |
|
1577
Ingersoll Rand
IR
$32.8B
| $662K | ﹤0.01% |
15,909
-20,905
| -57% | -$952K |
|
|
SCS
1578
DELISTED
Steelcase
SCS
| $661K | ﹤0.01% |
61,586
-9,186
| -13% | -$106K |
|
|
BCOV
1579
DELISTED
Brightcove, Inc.
BCOV
| $661K | ﹤0.01% |
104,539
-19,108
| -15% | -$135K |
|
1580
SiTime
SITM
$20.4B
| $659K | ﹤0.01% |
4,113
-10,356
| -72% | -$1.96M |
|
1581
Tenable Holdings
TENB
$4.15B
| $656K | ﹤0.01% |
14,446
-23,761
| -62% | -$1.22M |
|
1582
First Merchants
FRME
$2.69B
| $655K | ﹤0.01% |
18,376
-5,296
| -22% | -$208K |
|
1583
Precigen
PGEN
$2.48B
| $655K | ﹤0.01% |
488,801
+219,599
| +82% | +$326K |
|
|
INVX
1584
Innovex International
INVX
$2.07B
| $653K | ﹤0.01% |
25,308
+13,875
| +121% | +$423K |
|
1585
Arrowhead Research
ARWR
$12.7B
| $652K | ﹤0.01% |
19,540
-97,058
| -83% | -$3.65M |
|
1586
AngloGold Ashanti
AU
$49B
| $650K | ﹤0.01% |
43,935
-241,634
| -85% | -$4.58M |
|
1587
IDT Corp
IDT
$1.65B
| $650K | ﹤0.01% |
25,855
+12,726
| +97% | +$351K |
|
1588
St. Joe Company
JOE
$3.9B
| $650K | ﹤0.01% |
16,433
| – | – |
|
|
VLRS
1589
Controladora Vuela Compania de Aviacion
VLRS
$900M
| $650K | ﹤0.01% |
+63,297
| New | +$937K |
|
|
B
1590
Barrick Mining
B
$68B
| $649K | ﹤0.01% |
36,674
-2,323
| -6% | -$50.4K |
|
1591
Simply Good Foods
SMPL
$961M
| $648K | ﹤0.01% |
17,148
+2,230
| +15% | +$88.3K |
|
1592
Gorman-Rupp
GRC
$2.18B
| $646K | ﹤0.01% |
22,810
+10,815
| +90% | +$336K |
|
1593
Haverty Furniture Companies
HVT
$450M
| $644K | ﹤0.01% |
27,788
+1,491
| +6% | +$39.8K |
|
1594
PJT Partners
PJT
$4.47B
| $644K | ﹤0.01% |
9,163
-2,722
| -23% | -$189K |
|
1595
Valhi
VHI
$457M
| $644K | ﹤0.01% |
+14,208
| New | +$565K |
|
|
ALX
1596
Alexander's
ALX
$1.4B
| $643K | ﹤0.01% |
2,895
-240
| -8% | -$57.9K |
|
1597
Rayonier
RYN
$6.51B
| $641K | ﹤0.01% |
19,189
+1,205
| +7% | +$44.2K |
|
1598
TechTarget
TTGT
$275M
| $641K | ﹤0.01% |
9,751
-1,688
| -15% | -$118K |
|
1599
Outfront Media
OUT
$5.32B
| $638K | ﹤0.01% |
38,608
-26,997
| -41% | -$587K |
|
|
FYBR
1600
DELISTED
Frontier Communications
FYBR
| $637K | ﹤0.01% |
27,051
+5,545
| +26% | +$142K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.